BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 1670994)

  • 1. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas.
    Slagle BL; Zhou YZ; Butel JS
    Cancer Res; 1991 Jan; 51(1):49-54. PubMed ID: 1670994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent loss of chromosome 8p in hepatitis B virus-positive hepatocellular carcinomas from China.
    Becker SA; Zhou YZ; Slagle BL
    Cancer Res; 1996 Nov; 56(21):5092-7. PubMed ID: 8895769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
    Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
    Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.
    Fujimoto Y; Hampton LL; Wirth PJ; Wang NJ; Xie JP; Thorgeirsson SS
    Cancer Res; 1994 Jan; 54(1):281-5. PubMed ID: 7903205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].
    Tu H; Gao HF; Ma GH; Liu Y
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelotype study of primary hepatocellular carcinoma.
    Fujimori M; Tokino T; Hino O; Kitagawa T; Imamura T; Okamoto E; Mitsunobu M; Ishikawa T; Nakagama H; Harada H
    Cancer Res; 1991 Jan; 51(1):89-93. PubMed ID: 1670995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated state of subgenomic fragments of hepatitis B virus DNA in hepatocellular carcinoma from mainland China.
    Zhou YZ; Butel JS; Li PJ; Finegold MJ; Melnick JL
    J Natl Cancer Inst; 1987 Aug; 79(2):223-31. PubMed ID: 3037150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of somatic heterozygosity in hepatocellular carcinoma.
    Walker GJ; Hayward NK; Falvey S; Cooksley WG
    Cancer Res; 1991 Aug; 51(16):4367-70. PubMed ID: 1678314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
    Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
    Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
    Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
    Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
    Nishida N; Fukuda Y; Kokuryu H; Toguchida J; Yandell DW; Ikenega M; Imura H; Ishizaki K
    Cancer Res; 1993 Jan; 53(2):368-72. PubMed ID: 8093350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma.
    Henkler F; Waseem N; Golding MH; Alison MR; Koshy R
    Cancer Res; 1995 Dec; 55(24):6084-91. PubMed ID: 8521397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China.
    Scorsone KA; Zhou YZ; Butel JS; Slagle BL
    Cancer Res; 1992 Mar; 52(6):1635-8. PubMed ID: 1311638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
    Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
    Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
    Hosono S; Chou MJ; Lee CS; Shih C
    Oncogene; 1993 Feb; 8(2):491-6. PubMed ID: 8093978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of integration patterns and flanking cellular sequences of hepatitis B virus in childhood hepatocellular carcinomas.
    Tsuei DJ; Chang MH; Chen PJ; Hsu TY; Ni YH
    J Med Virol; 2002 Dec; 68(4):513-21. PubMed ID: 12376959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.
    Bressac B; Kew M; Wands J; Ozturk M
    Nature; 1991 Apr; 350(6317):429-31. PubMed ID: 1672732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis.
    Wang Y; Lau SH; Sham JS; Wu MC; Wang T; Guan XY
    Oncogene; 2004 Jan; 23(1):142-8. PubMed ID: 14712219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.